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Introduction {#sec006}
============

In many countries, population ageing is taking place as a result of longer life expectancy and declining fertility rates. Globally, the number of older people (aged 60 years or over) is expected to grow to more than two billion, reaching 21.1% of the world's population by 2050 \[[@pone.0173075.ref001]\]. Although sleeping problems are not an inherent part of the ageing process, many older adults suffer from sleeping problems such as sleep apnea and insomnia \[[@pone.0173075.ref002]\]. Sleep disordered breathing (SDB) is a highly prevalent disorder that commonly occurs in the elderly \[[@pone.0173075.ref003]\]. The prevalence of insomnia tends to be higher in older individuals with multiple physical and mental conditions \[[@pone.0173075.ref002]\]. These sleep disorders have a substantial socioeconomic impact on both the individual and society, eliciting negative consequences in quality of life, psychological and physical performance, and mortality \[[@pone.0173075.ref002]--[@pone.0173075.ref004]\].

In the past, asthma and allergic rhinitis were mostly regarded as diseases of childhood. However, recent literature has indicated the high epidemiologic burden of asthma, and underestimation of allergic rhinitis, in the elderly. Cross sectional surveys have reported that the prevalence of asthma is 4.5%--12.7% in the elderly \[[@pone.0173075.ref005], [@pone.0173075.ref006]\]. Asthma is often more prevalent in the elderly than in younger adults both when examined using a self-administered questionnaire or measurement of airway hyperresponsiveness \[[@pone.0173075.ref007], [@pone.0173075.ref008]\]. Furthermore, recent observations have suggested a high prevalence of rhinitis in the elderly \[[@pone.0173075.ref009], [@pone.0173075.ref010]\]. Results from the National Health and Nutrition Examination Survey found that the self-reported prevalence of rhinitis was approximately 32% in older adults aged between 54 and 89 years, similar to the prevalence in younger adults \[[@pone.0173075.ref009]\]. Allergic sensitization is generally known to decrease with age \[[@pone.0173075.ref009], [@pone.0173075.ref011]\]. However, recent reports have indicated that allergic rhinitis and local allergic rhinitis are common in the elderly, suggesting that allergic rhinitis may be underestimated in this population \[[@pone.0173075.ref012]\].

Numerous reports have indicated that SDB and sleep disturbance are commonly associated with asthma and allergic rhinitis \[[@pone.0173075.ref013], [@pone.0173075.ref014]\]. Rhinitis and upper airway disease are well-known risk factors for obstructive sleep apnea (OSA). Nasal obstruction and resistance increases respiratory events and arousals during sleep, leading to sleep fragmentation \[[@pone.0173075.ref014]\]. OSA and asthma are known to be frequently co-morbid and share risk factors such as obesity, rhinitis, and gastroesophageal reflux \[[@pone.0173075.ref013]\]. OSA increases the risk for asthma and affects control status, and the risk for OSA is increased in asthmatics \[[@pone.0173075.ref013]\]. Night-time worsening of asthma is a well-known phenomenon and may induce sleep disturbance \[[@pone.0173075.ref015]\]. Furthermore, many medications given to treat asthma and allergic rhinitis may affect sleep quality as a result of adverse effects such as drowsiness and insomnia \[[@pone.0173075.ref016]\]. Despite the large amount of evidence suggesting the impact of asthma and rhinitis on sleep quality, studies conducted in elderly adults using polysomnography assessment of sleep-related disorders are rare. In this study, we investigated the impact of self-reported rhinitis and asthma on sleep apnea and sleep quality using polysomnography in an elderly Korean population.

Methods {#sec007}
=======

Study subjects {#sec008}
--------------

This study was conducted with cross-sectional manner using a subpopulation of The Korean Longitudinal Study on Cognitive Aging and Dementia, a population-based cohort study in an elderly Korean population aged ≥60 years \[[@pone.0173075.ref017]\]. We enrolled 348 elderly subjects who agreed to receive a nocturnal polysomnography study among randomly selected samples in Yong-In city, Korea. Sample size was calculated based on assumption of effect size and prevalence of SDB with α error of 0.05 and power (1-β) of 0.85. Prevalence of asthma in SDB group and non-SDB group were expected to be 15% and 5%, respectively based on previous report \[[@pone.0173075.ref018]\]. Prevalence of SDB in the elderly population was expected to be 30--40%. Study subjects underwent a polysomnography study, and anthropometric and clinical evaluations including height, weight, and neck, waist, and hip circumference, and blood pressure when they received baseline cohort registration work-up. The Pittsburg sleep quality index (PSQI) was used to assess subjective sleep complaints and quality. Simultaneously, prevalence and the comorbid status of asthma and allergic rhinitis were evaluated using questionnaires. This study was approved by institutional review board of Seoul National University Bundang Hospital (approval number: B-1006/103-010) and all subjects provided written informed consent themselves or via their legal guardians.

Nocturnal polysomnography {#sec009}
-------------------------

One night of polysomnography was recorded using Embla^™^ N7000 (Embla, Reykjavik, Iceland). Briefly, electroencephalography (EEG), electrooculography, and electromyography electrodes were applied at the appropriate positions to record EEG, eye, and muscle movements. Strain gauges were used to record chest and abdominal respiratory movements and nasal pressure cannulas were employed to record airflow. Oxygen saturation was measured using a pulse oximeter applied to the index finger. Sleep was scored at every 30-second epoch of the nocturnal polysomnography based on the criteria of Rechtschaffen and Kales \[[@pone.0173075.ref019]\]. The apnea and hypopnea index (AHI) was defined as the total number of apneas and hypopneas per hour of sleep. Apnea was defined as complete cessation of airflow for at least 10 seconds. Hypopnea was defined as a clear decrease of airflow (\>50%) for at least 10 seconds or a discernible reduction in airflow for at least 10 seconds associated with electroencephalographic arousal or oxygen desaturation \[[@pone.0173075.ref020]\]. SDB usually stands for sleep apnea syndrome, although it is broad term describing disorders of respiratory pattern or quantity of ventilation that occur periodically during sleep. SBD was defined as obstructive and central sleep apnea, and the criterion for SDB was defined as AHI≥15 in this study \[[@pone.0173075.ref021]\]. In-addition, sleep-related parameters including waking after sleep onset, sleep onset latency, sleep efficiency (the number of minutes of sleep divided by the number of minutes in bed), respiratory arousal, lowest O~2~ saturation, O~2~ desaturation index, and mean apnea duration were analyzed to assess sleep quality and sleep-disordered breathing status.

Questionnaire for co-morbidity of asthma and rhinitis {#sec010}
-----------------------------------------------------

Evaluations for the prevalence and co-morbidity of asthma and allergic rhinitis were performed using a self-administered questionnaire, which was modified from the Korean adult general population asthma & rhinitis survey questionnaire \[[@pone.0173075.ref022], [@pone.0173075.ref023]\]. The questionnaire consisted of nine main questions and seven collateral questions asking about symptoms and a medical history of asthma and allergic rhinitis. Regarding asthma, subjects were asked the following: (i) Have you experienced any wheezing during the past 12 months? (ii) Have you ever been diagnosed with asthma? (iii) Have you received any treatment for asthma during the past 12 months? Regarding allergic rhinitis, subjects were asked the following: (i) Have you ever experienced sneezing and a stuffy nose during the past 12 months when you did not have a cold? (ii) Have you ever been diagnosed with allergic rhinitis? (iii) Have you received any treatment for allergic rhinitis during the past 12 months? Current asthma was defined as when the subject had current wheezing and a physician-made ever-diagnosis of asthma together.

Statistical analysis {#sec011}
--------------------

The t-test for continuous variables and chi-square test or Fisher exact test (for nonparametric results) for categorical variables was used to compare the clinical characteristics and prevalence of asthma and allergic rhinitis according to the presence of SDB. Univariate and multivariate analysis of affecting factors for SDB were performed with age, gender, BMI, neck circumference and history of allergic rhinitis using logistic regression test. The Mann-Whitney test was used to compare nonparametric sleep-related variables according to the co-morbid conditions of asthma and allergic rhinitis. Statistical analyses were performed using SPSS ver. 18.0 (SPSS, Inc., Chicago, IL, USA); *p*\<0.05 was deemed to indicate statistical significance.

Results {#sec012}
=======

Ever-diagnosis of allergic rhinitis as a risk factor for sleep-disordered breathing {#sec013}
-----------------------------------------------------------------------------------

A total of 127 subjects (36.5%) were diagnosed with SDB among the 348 participants when it was defined as AHI ≥15. SDB was significantly more predominant among male subjects. Subjects with SDB had higher BMI, and waist, hip, and neck circumference when compared with subjects without SDB. Diastolic BP was higher in the SDB group than the subjects without SDB, although there was no significant difference in systolic BP. Subjects with SDB showed higher rates of respiratory arousal, higher O~2~ desaturation index, longer mean apnea duration, and lower lowest O~2~ compared with subjects without SDB. However, high SDB was not related to sleep efficiency, waking after sleep onset, or PSQI. ([Table 1](#pone.0173075.t001){ref-type="table"})

10.1371/journal.pone.0173075.t001

###### Demographic and sleep characteristics of study subjects.

![](pone.0173075.t001){#pone.0173075.t001g}

  Characteristics                 Total (N = 348)   AHI\<15 (N = 221)   AHI≥15 (N = 127)   p-value
  ------------------------------- ----------------- ------------------- ------------------ ---------
  Age                             68.3±5.6          67.9±5.6            68.9±5.6           0.151
  Gender(male)                    135 (38.8%)       64 (29.0%)          71 (55.9%)         \<0.001
  BMI                             23.7±2.7          23.2±2.5            24.5±3.0           \<0.001
  Waist circumference             84.8±9.1          83.3±9.3            87.4±8.2           \<0.001
  Hip circumference               94.5±5.7          93.5±5.2            96.3±6.1           \<0.001
  Neck circumference              37.4±4.0          36.6±3.4            38.8±4.5           \<0.001
  SBP                             114.8±15.2        114.3±16.0          115.9±13.7         0.340
  DBP                             74.3±9.1          73.4±9.2            75.8±9.0           0.019
  Waking after sleep onset        95.9±62.0         93.1±58.6           100.7±67.6         0.273
  Total sleep time                374.3±67.0        375.9±64.9          371.6±70.9         0.572
  Sleep onset latency             18.8±28.2         18.3±24.8           19.9±33.6          0.621
  Sleep efficiency                76.9±13.4         77.3±13.0           76.1±13.9          0.418
  Respiratory arousal             10.4±11.9         3.6±2.9             22.1±12.4          \<0.001
  Lowest O2                       86.0±5.6          88.0±4.2            82.7±6.0           \<0.001
  O2 desaturation index           10.9±12.8         4.2±7.1             22.6±12.3          \<0.001
  Mean apnea duration             18.2±9.2          15.6±9.4            22.8±6.8           \<0.001
  Pittsburg Sleep Quality Index   6.5±3.7           6.7±3.8             6.2±3.6            0.210

BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure

We analyzed the self-reported prevalence of asthma and allergic rhinitis among subjects with SDB. Self-reported ever-diagnosis of allergic rhinitis was significantly more prevalent in the subjects with SDB compared with those without SDB (22.6% vs. 13.6%, adjusted p = 0.046). No significant difference between groups was observed in the presence of current asthma, ever-diagnosis of asthma, asthma treatment within the past 12 months, rhinitis symptoms within the past 12 months, or allergic rhinitis treatment within the past 12 months. ([Table 2](#pone.0173075.t002){ref-type="table"}) Multivariate analysis revealed history of allergic rhinitis (self-reported ever-diagnosis of allergic rhinitis) is a significant risk factors affecting SDB after adjustment of other risk factors of SDB including age, gender, BMI, and neck circumference. ([Table 3](#pone.0173075.t003){ref-type="table"})

10.1371/journal.pone.0173075.t002

###### Prevalence of asthma and rhinitis according to sleep disordered breathing.

![](pone.0173075.t002){#pone.0173075.t002g}

  Clinical features                     Total (N = 348)   AHI\<15 (N = 221)   AHI≥15 (N = 127)   p-value
  ------------------------------------- ----------------- ------------------- ------------------ ---------
  Current asthma                        9 (2.6%)          8 (3.7%)            1 (0.8%)           0.163
  Ever-diagnosis of asthma              21 (6.2%)         14 (6.5%)           7 (5.6%)           0.750
  Asthma treatment, past 12 months      15 (4.4%)         9 (4.1%)            6 (4.6%)           0.777
  Rhinitis symptoms, past 12 months     96 (28.7%)        58 (27.6%)          38 (30.4%)         0.586
  Ever-diagnosis of allergic rhinitis   57 (16.9%)        29 (13.6%)          28 (22.6%)         0.034
  Allergic rhinitis, past 12 months     32 (9.4%)         16 (7.5%)           16 (12.7%)         0.114

10.1371/journal.pone.0173075.t003

###### Univariate and multivariate analysis of affecting factors for sleep disordered breathing.

![](pone.0173075.t003){#pone.0173075.t003g}

  Variables                      Unadjusted          Adjusted[\*](#t003fn001){ref-type="table-fn"}                       
  ------------------------------ ------------------- ----------------------------------------------- ------------------- ---------
  Age                            1.03 (0.99--1.07)   0.151                                           1.03 (0.99--1.08)   0.127
  Gender                         3.11 (1.97--4.90)   \<0.001                                         2.99 (1.65--5.41)   \<0.001
  BMI                            1.21 (1.11--1.32)   \<0.001                                         1.23 (1.11--1.36)   \<0.001
  Neck circumference             1.19 (1.11--1.28)   \<0.001                                         1.02 (0.97--1.11)   0.654
  History of allergic rhinitis   1.85 (1.04--3.29)   0.036                                           1.90 (1.01--3.57)   0.046

\*adjusted for all variables shown using logistic regression test

Impairment of sleep quality in subjects with recent treatment of asthma or allergic rhinitis {#sec014}
--------------------------------------------------------------------------------------------

Sleep quality and SDB-related parameters were affected by comorbid allergic rhinitis more than comorbid asthma. Subjects with self-reported ever-diagnosis of allergic rhinitis showed a higher O~2~ desaturation index (13.9±15.2 vs. 10.5±12.4, p = 0.022) and mean apnea duration (21.9±10.8 vs. 17.6±8.7, p = 0.027), although AHI was not significantly different. On the other hand, indices regarding sleep disturbances were affected in subjects who had received allergic rhinitis treatment within the past 12 months. Waking after sleep onset was longer (123.1±71.4 vs. 93.9±60.8, p = 0.017) and sleep efficiency was lower (71.7±14.6 vs. 77.3±13.2, p = 0.028) in subjects who had received allergic rhinitis treatment within the past 12 months. The PSQI score was also significantly higher in the allergic rhinitis treatment within the past 12 months group (8.2±4.5 vs. 6.4±3.6, p = 0.024). Subjects with rhinitis symptoms within the past 12 months showed a higher PSQI (7.5±3.9 vs. 6.1±3.5, p = 0.001) and longer mean apnea duration (20.5±9.4 vs. 17.6±9.0, p = 0.037). ([Table 4](#pone.0173075.t004){ref-type="table"}) In addition, the proportions of sleep stages were analyzed according to the comorbid status of rhinitis and asthma. The percentage of non-rapid eye movement (non-REM) stage 2 sleep was significantly lower in subjects with an ever-diagnosis of allergic rhinitis than in those without a diagnosis (42.3±9.9 vs. 46.7±11.6, p = 0.036). Subjects who had rhinitis symptoms within the past 12 months showed significantly lower percentage of non-REM stage 3 sleep indicating deep sleep (5.7±6.1 vs. 6.9±5.3, p = 0.017). In the analysis of sleep parameters according to comorbid asthma, subjects who had received asthma treatment within the past 12 months showed significantly lower sleep efficiency than others (68.9±16.7 vs. 77.2±13.2, p = 0.043). Otherwise, we could not find any associations between sleep parameters and asthma in our study subjects. ([Table 5](#pone.0173075.t005){ref-type="table"})

10.1371/journal.pone.0173075.t004

###### Sleep parameters in polysomnography and sleep quality index according to co-morbidity of allergic rhinitis.

![](pone.0173075.t004){#pone.0173075.t004g}

  Parameters                      Rhinitis symptoms, past 12 months   p-value     Ever-diagnosis of allergic rhinitis   p-value      Allergic rhinitis treatment, past 12 months   p-value                            
  ------------------------------- ----------------------------------- ----------- ------------------------------------- ------------ --------------------------------------------- --------- ------------ ----------- -------
  Apnea Hypopnea Index            16.1±14.5                           15.0±14.8   0.283                                 16.7±13.7    15.0±15.0                                     0.112     17.0±15.6    15.1±14.7   0.443
  Obstructive apnea index         5.9±9.0                             5.8±9.5     0.256                                 6.4±8.7      5.7±9.4                                       0.055     6.9±9.9      5.7±9.2     0.216
  Central apnea index             0.6±1.2                             0.6±2.2     0.591                                 0.6±1.3      0.6±2.1                                       0.834     0.5±0.9      0.6±2.1     0.686
  Mixed apnea index               0.8±2.8                             0.6±2.9     0.992                                 0.9±2.4      0.6±2.9                                       0.090     0.9±2.2      0.6±2.9     0.072
  Hypopnea index                  8.8±7.4                             8.0±7.0     0.230                                 8.8±6.8      8.1±7.4                                       0.205     8.8±7.7      8.1±7.3     0.645
  Waking after sleep onset        105.3±71.3                          93.4±58.6   0.310                                 106.1±68.6   94.5±59.0                                     0.274     123.1±71.4   93.9±60.8   0.017
  Sleep efficiency                75.4±14.7                           77.3±13.0   0.424                                 75.0±14.6    77.0±13.1                                     0.369     71.7±14.6    77.3±13.2   0.028
  Stage 1 sleep (%)               13.8±6.9                            14.0±7.5    0.890                                 13.4±6.5     14.0±7.4                                      0.732     13.7±7.4     13.9±7.3    0.836
  Stage 2 sleep (%)               45.1±11.2                           46.2±11.6   0.242                                 44.5±10.8    46.3±11.7                                     0.352     42.3±9.9     46.5±11.7   0.036
  Stage 3 sleep (%)               5.7±6.1                             6.9±5.3     0.017                                 5.6±4.9      6.7±5.6                                       0.165     5.5±5.0      6.6±5.7     0.310
  REM sleep (%)                   15.3±6.0                            14.8±5.8    0.550                                 15.7±5.6     14.8±5.9                                      0.286     14.4±5.7     15.0±5.8    0.661
  Respiratory arousal             11.1±11.6                           10.3±12.2   0.243                                 11.3±11.4    10.3±12.1                                     0.211     11.9±12.6    10.4±11.9   0.399
  Lowest O2                       85.2±6.2                            86.2±5.3    0.131                                 85.1±5.0     86.2±5.6                                      0.064     85.7±5.5     86.0±5.6    0.712
  O2 desaturation index           12.3±14.6                           10.6±12.2   0.296                                 13.9±15.2    10.5±12.4                                     0.022     14.8±18.6    10.7±12.2   0.237
  Mean apnea duration             20.5±9.4                            17.6±9.0    0.037                                 21.9±10.8    17.6±8.7                                      0.027     22.4±11.7    17.9±8.8    0.088
  Pittsburg Sleep Quality Index   7.5±3.9                             6.1±3.5     0.001                                 7.5±4.3      6.4±3.6                                       0.087     8.2±4.5      6.4±3.6     0.024

REM sleep, rapid eye movement sleep

10.1371/journal.pone.0173075.t005

###### Sleep parameters in polysomnography and sleep quality index according to co-morbidity of asthma.

![](pone.0173075.t005){#pone.0173075.t005g}

  Parameters                      Current asthma   p-value     Ever-diagnosis of asthma   p-value      Asthma treatment, past 12 months   p-value                            
  ------------------------------- ---------------- ----------- -------------------------- ------------ ---------------------------------- --------- ------------ ----------- -------
  Apnea Hypopnea Index            7.2±6.6          15.3±14.8   0.091                      16.6±21.1    15.1±14.3                          0.569     18.7±22.9    15.0±14.2   0.935
  Obstructive apnea index         0.3±1.2          5.8±9.3     0.173                      8.9±17.2     5.6±8.5                            0.819     11.1±20.0    5.5±8.4     0.709
  Central apnea index             0.2±0.4          0.6±2.0     0.711                      0.2±0.3      0.6±2.0                            0.455     0.2±0.4      0.6±2.0     0.926
  Mixed apnea index               0.0±0.1          0.7±2.9     0.187                      0.0±0.1      0.7±2.9                            0.354     0.1±0.1      0.7±2.9     0.550
  Hypopnea index                  5.7±5.9          8.2±7.3     0.239                      7.4±8.5      8.3±7.2                            0.278     7.3±6.7      8.2±7.3     0.677
  Waking after sleep onset        96.2±54.8        96.1±62.4   0.768                      117.3±72.5   94.5±59.9                          0.152     127.5±72.6   95.0±61.5   0.062
  Sleep efficiency                72.8±17.1        76.9±13.3   0.451                      70.3±17.6    77.2±13.1                          0.082     68.9±16.7    77.2±13.2   0.043
  Stage 1 sleep (%)               9.9±4.4          13.9±7.3    0.076                      13.9±7.4     13.9±7.3                           0.942     13.6±7.7     13.9±7.3    0.801
  Stage 2 sleep (%)               45.3±11.1        46.2±11.7   0.855                      42.6±12.3    46.2±11.5                          0.206     41.0±12.2    46.3±11.6   0.107
  Stage 3--4 sleep (%)            9.0±6.1          6.5±5.6     0.185                      6.4±6.2      6.5±5.5                            0.686     6.8±6.2      6.5±5.6     0.990
  REM sleep (%)                   17.2±7.7         14.9±5.6    0.403                      14.1±7.7     15.0±5.7                           0.423     13.8±8.1     15.0±5.7    0.388
  Respiratory arousal             3.7±3.3          10.5±12.0   0.073                      10.9±17.1    10.4±11.6                          0.374     13.4±19.6    10.3±11.5   0.928
  Lowest O2                       87.6±2.7         86.0±5.6    0.493                      87.4±3.2     85.9±5.7                           0.411     86.8±3.0     86.0±5.6    0.892
  O2 desaturation index           5.0±5.5          11.1±13.0   0.174                      11.6±14.2    11.0±12.9                          0.810     12.8±14.1    10.8±12.9   0.591
  Mean apnea duration             16.0±4.2         18.3±9.4    0.175                      18.7±4.9     18.3±9.4                           0.908     18.5±5.7     18.3±9.4    0.817
  Pittsburg Sleep Quality Index   5.8±2.2          6.6±3.8     0.824                      6.8±3.5      6.5±3.7                            0.593     6.2±3.0      6.5±3.8     0.975

REM sleep, rapid eye movement sleep

Discussion {#sec015}
==========

In the present study, we performed nocturnal polysomnography in an elderly Korean population randomly selected from the community. The prevalence of SDB, defined as AHI≥15, was as high as 36.5% and subjects with SDB showed higher respiratory arousal, O~2~ desaturation index, and mean apnea duration. SDB is an umbrella term used to describe disorders of respiratory pattern or quantity of ventilation that occur periodically during sleep, and is commonly associated with OSA \[[@pone.0173075.ref003]\]. OSA is characterized by partial or complete cessation of airflow and oxygen desaturation during sleep as a result of upper airway collapse. The nose accounts for a large part of the total resistance of the upper airway and any factors causing nasal obstruction can lead to snoring or apnea \[[@pone.0173075.ref014]\]. Elevation of nasal resistance can also promote inspiratory collapse at the pharyngeal level increasing negative pressure in the upper airway. Chronic nasal inflammatory conditions, such as allergic rhinitis, appear to contribute to upper airway obstruction in OSA \[[@pone.0173075.ref024]\]. Numerous studies have demonstrated that allergic rhinitis can predispose an individual to or worsen the symptoms of OSA. It was reported that subjects with persistent nasal congestion owing to allergy are 1.8 times more likely to have moderate to severe SDB than subjects without nasal congestion from allergy \[[@pone.0173075.ref025]\]. In accordance with previous reports, our study showed that SDB was associated with male sex, high BMI, large neck circumference, and high blood pressure. Furthermore, a self-reported history (ever-diagnosis by physicians) of allergic rhinitis was significantly more prevalent in subjects with SDB even after adjusting for confounding factors including age, gender, BMI, and neck circumference. This data indicates that a history of allergic rhinitis is associated with increased risk of SDB in the elderly population.

Allergic rhinitis has been recognized relatively less commonly in the elderly. It has been long believed that allergic sensitization diminishes with age and non-allergic rhinitis is more common in the elderly. The low incidence and high remission rate of allergic sensitization were reported in the long-term follow up of an adult population \[[@pone.0173075.ref011]\]. However, rhinitis is also prevalent in the elderly population with prevalence as high as 32%, which was not significantly different from that in younger adults \[[@pone.0173075.ref009]\]. Some reports have indicated that the change in rhinitis symptoms seems not related with the change of skin test reactivity in older adults \[[@pone.0173075.ref026], [@pone.0173075.ref027]\]. Non-allergic rhinitis at the initial evaluation can often be converted into allergic rhinitis at the second evaluation in the adult population \[[@pone.0173075.ref028]\]. Moreover, recent studies have revealed a subtype of allergic rhinitis which just has localized IgE-mediated allergic inflammation in the nasal mucosa without a positive skin test or blood-specific IgE to aeroallergen \[[@pone.0173075.ref029]\]. A high prevalence of local allergic rhinitis has been observed in elderly patients with rhinitis \[[@pone.0173075.ref012]\]. These data implicate that a substantial proportion of elderly patients with rhinitis might have an aeroallergen allergy and persistence of symptoms despite their low skin test reactivity.

In our study, only self-reported ever-diagnosis of allergic rhinitis was associated with SDB, while rhinitis symptoms or treatment of allergic rhinitis within the past 12 months were not. This result might imply that a clinical history of nasal allergy itself is a more critical risk factor for SDB rather than nasal symptoms such as obstruction or discharge, although the exact mechanism is not clear. Some reports have highlighted OSA as a pro-inflammatory disorder that co-aggregates with obesity, interacting with respiratory allergic diseases \[[@pone.0173075.ref030]\]. Chronic local and systemic inflammatory conditions in subjects who have an ever-diagnosis of allergic rhinitis may affect the development and severity of SDB. Interestingly, ever-diagnosis of allergic rhinitis had a negative influence on parameters related with SDB such as the O~2~ desaturation index and mean apnea duration, but did not significantly affect sleep efficiency as measured using polysomnography and PSQI. Meanwhile, treatment for allergic rhinitis or rhinitis symptoms within the past 12 months contribute to poor sleep quality and sleep efficiency more than parameters related with SDB. Insomnia and SDB could be co-occurring \[[@pone.0173075.ref031]\], but some studies have revealed inconsistent results about their co-occurrence \[[@pone.0173075.ref032], [@pone.0173075.ref033]\]. The degree of SDB does not seem to be always correlated with sleep efficiency or subjective sleep quality. Characteristics of sleep disturbance, sleep apnea, or insomnia might differ according to the comorbid conditions of rhinitis such as the type of rhinitis, severity of symptoms and inflammation, disease duration, upper airway complications, and medications. Nasal obstruction or airflow resistance in the upper airway can contribute to both poor sleep efficiency and sleep apnea. However, nasal discharge and an itching sensation is likely to impair sleep efficiency eliciting insomnia and waking rather than SDB \[[@pone.0173075.ref034]\]. Many medications used in the treatment of allergic rhinitis may have potential adverse effects on patients' sleep quality. Although first generation antihistamine can be used to treat insomnia because of their sedative effect, decongestants frequently combined with antihistamines are well-known to cause insomnia \[[@pone.0173075.ref035]\]. A review of the pharmacovigilance program of the World Health Organization revealed that intranasal corticosteroids as well as systemic corticosteroids can be complicated by neuropsychiatric adverse reactions including insomnia \[[@pone.0173075.ref036]\]. Older adults are more prone to sleep disturbance than younger adults \[[@pone.0173075.ref002]\]. Our data support that physicians need to pay more attention to poor sleep quality and efficiency in elderly patients who have current symptoms of rhinitis and are taking rhinitis medications.

Many epidemiologic studies reported a high risk of OSA in asthmatic patients and a high risk of asthma in adults with OSA \[[@pone.0173075.ref013]\]. These two diseases are bi-directionally linked with overlapping risk factors such as rhinitis, obesity, and gastroesophageal reflux \[[@pone.0173075.ref013], [@pone.0173075.ref030]\]. OSA may have an influence on asthmatic symptom control and asthma-related quality of life \[[@pone.0173075.ref037], [@pone.0173075.ref038]\]. Suggested potential pathophysiologic mechanisms include neuromechanical effects of upper airway collapse, systemic and airway inflammation enhanced by chronic intermittent hypoxia or obesity, and sleep fragmentation \[[@pone.0173075.ref013], [@pone.0173075.ref030]\]. In addition, several studies have suggested that taking oral or inhaled corticosteroids may lead to the development of OSA through parapharyngeal fat deposition and myopathy because of corticosteroid use \[[@pone.0173075.ref039], [@pone.0173075.ref040]\]. In contrast to the large amount of evidence in patients with asthma or OSA, population-based association studies are rare. One European study in the general population reported a high prevalence of snoring (17%) and witnessed apnea (14%) in subjects with physician-diagnosed asthma compared with the overall prevalence \[[@pone.0173075.ref041]\]. A recent population-based prospective study demonstrated asthma is associated with increased risk of new onset OSA \[[@pone.0173075.ref042]\]. However, population-based studies utilizing polysomnography to identify the prevalence and severity of OSA in asthma have not been reported yet, especially in elderly populations. We evaluated the associations between SDB and asthma in an elderly Korean population using polysomnography, but an association was not found in our study. Although the small number of current asthmatics and subjects with a self-reported ever-diagnosis of asthma might have limited adequate evaluation, our data suggest a possibility that the linkage between OSA and asthma is not clear in the elderly. Elderly asthma is reported to be considerably distinct from the disease in childhood and young adults in terms of clinical characteristics and risk factors \[[@pone.0173075.ref043]\]. Further studies are warranted to clarify this issue more clearly in the future. Meanwhile, it is noticeable that subjects with asthma treatment within the past 12 months showed significantly poorer sleep efficiency on polysomnography, similar to the case for allergic rhinitis. This suggests that other types of sleep disturbance may happen in asthmatics who have symptoms or have taken asthma medications recently.

Our study has several limitations. First, the prevalence of asthma and allergic rhinitis were evaluated using a self-reported questionnaire without objective tests such as spirometry with bronchodilator response, a bronchial provocation test, or allergy skin test. Recall bias can be an issue in the elderly population. Although the questions about diagnosis of asthma and allergic rhinitis were based on previous diagnosis by a physician, it is possible that other differential medical conditions, such as chronic obstructive pulmonary disease or non-allergic rhinitis, might be misdiagnosed in the elderly. However, chronic obstructive pulmonary disease would not be a big problem in our study subjects. Smoking did not affect prevalence of current asthma and recent asthma treatment at all. (data not shown) There was no current smoker in subjects with ever-diagnosed asthma or recent asthma treatment. Proportion of ex-smoker who had smoked over 10pack year was also small. (4 of 21 subject with ever-diagnosed asthma and 2 of 15 subjects with recent asthma treatment) Second, the sample size of the study was insufficient to evaluate the association between asthma and OSA as mentioned earlier. Originally the sample size of the study was determined based on the expected prevalence of SDB in the elderly. Some previous studies have reported a prevalence of rhinitis and asthma as high as 32% and 12.7%, respectively. However, the self-reported prevalence of asthma and rhinitis was lower than our expectation in this study. In particular, the small population of asthmatics in our study subjects limited the adequate evaluation of the association between asthma and OSA.

Nonetheless, our study has important clinical implications in managing elderly patients who have sleep disorders or respiratory allergic diseases. We demonstrated that a history of allergic rhinitis can be a risk factor for SDB in the elderly as well as younger adults. In the polysomnography study of an elderly population, sleep disturbance and impaired sleep efficiency were found in the subjects who had received recent treatment of allergic rhinitis or asthma. Physicians should be aware that older patients with allergic rhinitis and asthma are susceptible to sleep problems when they have active symptoms or take medications for these diseases.
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